Last updated on May 2020

Efficacy Safety and Tolerability of Atogepant for the Prevention of Chronic Migraine

Brief description of study

This study will evaluate the efficacy, safety and tolerability of atogepant in participants with chronic migraine. This study includes a 12-week treatment period.

Clinical Study Identifier: NCT03855137

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.